Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the interest coverage ratio high or low?
The interest coverage ratio of -22.78x is 12% below its 5-year average of -20.41x, near the high end of its 5-year range (-703.64x–-10.41x).
32.17% above its 12-month average of -33.58x.
Reported quarterly interest coverage; no daily interpolation. Q2 FY2026 (2026-06-30): -16.98x.
INTEREST COVERAGE RATIO
-22.78x
INTEREST COVERAGE RATIO AVG TTM
-33.58x
INTEREST COVERAGE RATIO AVG 3Y
-15.89x
INTEREST COVERAGE RATIO AVG 5Y
-20.41x
INTEREST COVERAGE RATIO AVG 10Y
N/A
INTEREST COVERAGE RATIO AVG 15Y
N/A
INTEREST COVERAGE RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
+32.17%
CURRENT VS 3Y AVG
-43.40%
CURRENT VS 5Y AVG
-11.63%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-4.99x
median of 389 covered companies
CURRENT VS SECTOR MEDIAN
-356.51%
vs the sector median at left
Candel Therapeutics, Inc.
Market Cap
$743.33M
Interest Coverage Ratio
-22.78x
TTM Avg
-33.58x
3Y Avg
-15.89x
5Y Avg
-20.41x
Market Cap
$749.48M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$750.01M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$723.04M
Interest Coverage Ratio
N/A
TTM Avg
578.36x
3Y Avg
578.36x
5Y Avg
578.36x
Market Cap
$764.02M
Interest Coverage Ratio
-5.87x
TTM Avg
6.84x
3Y Avg
6.84x
5Y Avg
3.53x
Market Cap
$722.55M
Interest Coverage Ratio
-85.20x
TTM Avg
23.14x
3Y Avg
23.14x
5Y Avg
23.14x
Market Cap
$766.63M
Interest Coverage Ratio
1.73x
TTM Avg
1.55x
3Y Avg
1.27x
5Y Avg
1.31x
Market Cap
$717.21M
Interest Coverage Ratio
-67.01x
TTM Avg
15.61x
3Y Avg
8.76x
5Y Avg
6.40x
Market Cap
$773.03M
Interest Coverage Ratio
-1.65x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | INTEREST COVERAGE RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Candel Therapeutics, Inc. (CADL) | $743.33M | -22.78x | -33.58x | -15.89x | -20.41x |
| Design Therapeutics, Inc. (DSGN)vs › | $749.48M | N/A | N/A | N/A | N/A |
| Attovia Therapeutics, Inc. (ATTO)vs › | $750.01M | N/A | N/A | N/A | N/A |
| Avalo Therapeutics, Inc. (AVTX)vs › | $723.04M | N/A | 578.36x | 578.36x | 578.36x |
| Lexicon Pharmaceuticals, Inc. (LXRX)vs › | $764.02M | -5.87x | 6.84x | 6.84x | 3.53x |
| Cytek Biosciences, Inc. (CTKB)vs › | $722.55M | -85.20x | 23.14x | 23.14x | 23.14x |
| Mesa Laboratories, Inc. (MLAB)vs › | $766.63M | 1.73x | 1.55x | 1.27x | 1.31x |
| Achieve Life Sciences, Inc. (ACHV)vs › | $717.21M | -67.01x | 15.61x | 8.76x | 6.40x |
| Geron Corporation (GERN)vs › | $773.03M | -1.65x | N/A | N/A | N/A |
| Collegium Pharmaceutical, Inc. (COLL)vs › | $704.46M | 2.27x | 2.29x | 1.77x | 1.65x |
Interest Coverage
-22.8x
Debt/Equity
0.39
Current Ratio
16.09
Formula: Interest Coverage = EBIT / Interest Expense
Reference ranges:
Note: Interest coverage should be compared with historical interest expense, operating income, and industry capital structure.
Interest Coverage = EBIT / Interest Expense
The interest coverage ratio measures operating earnings relative to interest expense.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | INTEREST COVERAGE RATIO |
|---|---|
| 2026-06-30 | -16.98x |
| 2026-03-31 | -10.41x |
| 2025-12-31 | -11.12x |
| 2025-09-30 | -82.03x |
| 2025-06-30 | -47.36x |
| 2025-03-31 | -26.57x |
| 2024-12-31 | -20.87x |
| 2024-09-30 | -17.98x |
| 2024-06-30 | -15.12x |
| 2024-03-31 | -12.23x |
| 2023-12-31 | -15.33x |
| 2023-09-30 | -13.25x |
| 2023-06-30 | -14.87x |
| 2023-03-31 | -15.82x |
| 2022-09-30 | -17.11x |
| 2022-06-30 | -20.12x |
| 2022-03-31 | -51.35x |
| 2021-12-31 | -703.64x |
| 2021-06-30 | -353.40x |
| 2021-03-31 | -388.08x |
| 2020-03-31 | -32.19x |
